Bill Detail
H.R. 7837
Congress: 119
Title
Most Favored Patient Act of 2026
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Rep. Daniel Meuser [R-PA-9]
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Status as of Aug 5, 8:16 PM · synced 8d ago
Introduced
2026-03-05
Data source mode: congress-gov
Bill Engagement
Most Favored Patient Act of 2026
Lobbyists on the case
- Pharmaceutical Research and Manufacturers of America1 filing · 22 lobs
- Meredith Allison2026 Q1Pharmaceutical Research and Manufacturers of America · Intern - Senator Richard Burr; Intern - Senator Roger Wicker
- Gary Beck2026 Q1
Prepared intelligence brief
Put this record in the joined picture.
Unlock every organization and lobbyist filing on this bill, the complete event and issue map, private team positions, and recurring movement alerts across the portfolio.